In vitroantimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria-Reference-Cited by-同舟云学术

In vitroantimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria

Published:2015-12-07 Issue:3 Volume:71 Page:670-677
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:J. Antimicrob. Chemother.

Author:

Ito Akinobu,Kohira Naoki,Bouchillon Samuel K.,West Joshua,Rittenhouse Stephen,Sader Helio S.,Rhomberg Paul R.,Jones Ronald N.,Yoshizawa Hidenori,Nakamura Rio,Tsuji Masakatsu,Yamano Yoshinori

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/71/3/670/6993403/dkv402.pdf

Reference47 articles.

1. Antimicrobial susceptibility among Gram-positive and Gram-negative isolates collected in Europe between 2004 and 2010

2. In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011

3. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance

4. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages

5. Global spread of carbapenem-resistant Acinetobacter baumannii

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro activity of cefiderocol against carbapenemase-producing and meropenem-non-susceptible Gram-negative bacteria collected in the Japan Antimicrobial Resistant Bacterial Surveillance;Journal of Global Antimicrobial Resistance;2024-09

2. Should we, and how to, optimize cefiderocol administration during severe nosocomial pneumonia due to carbapenem-resistant Acinetobacter baumanii? A viewpoint;Journal of Global Antimicrobial Resistance;2024-09

3. Evaluation and optimization of sample size of neonates and infants for pediatric clinical studies on cefiderocol using a model‐based approach;Pharmacology Research & Perspectives;2024-08-23

4. Cefiderocol-Based Regimen for Acinetobacter NDM-1 Outbreak;Antibiotics;2024-08-15

5. In vitro activity of cefiderocol against European Enterobacterales, including isolates resistant to meropenem and recentβ-lactam/β-lactamase inhibitor combinations;Microbiology Spectrum;2024-08-06